
- BioPharm International-10-15-2020
- Volume 2020 eBook
- Issue 3
Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Pharmaceutical development is a long, risky, and expensive process. In this highly competitive market, pharmaceutical companies are under constant pressure to deliver innovation via new therapeutics, new technology, and improved efficiency and effectiveness (1). Precompetitive collaboration is recognized as a mechanism to enhance efficiency, mitigate risks, and share costs that can benefit industry, academia, and government agencies. For the purposes of this viewpoint, “precompetitive collaboration” may be defined as collaborations between pharmaceutical companies and third parties to produce an efficiency-enhancing advancement or refinement that will be made broadly available to the public (i.e., publication, commercialization of a new product).
Article Details
BioPharm International
eBook: Regulatory Sourcebook, October 2020
October 2020
Pages: 45–49
Citation
When referring to this article, please cite it as M. M. Faul et al.,“Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation," BioPharm International Regulatory Sourcebook eBook (October 2020).
Articles in this issue
almost 5 years ago
Bio/Pharma Industry Works Overtime to Find COVID-19 Therapiesalmost 5 years ago
GMPs Guide COVID-19 Vaccine Manufacturingalmost 5 years ago
Viral Vector API Characterization of Product-Related Impuritiesalmost 5 years ago
Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?almost 5 years ago
Tackling Cybersecurity Challenges in Legacy Systemsalmost 5 years ago
Enhancing Process Validation for Sterile Liquid and Freeze-Dried Formsalmost 5 years ago
Due Diligence Assessment of CMC Activitiesalmost 5 years ago
Strong Quality Culture: A How-To for Busy Managersalmost 5 years ago
Resources, Guidelines, and Guidance Documentsalmost 5 years ago
Regulatory and Standard Setting OrganizationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.